This paper describes work to improve the targeting of drug delivery for such infections by modifying intranasal spray usage protocols. Computational fluid dynamic studies and experimental validation work show that with an improved protocol, involving more shallowed (almost horizontal) angling of the intranasal spray, drug delivery to the nasopharyngeal viral infection ‘hot spot’ can be doubled. The optimal droplet size for drug delivery for such applications is discussed, and the robustness of the developed protocol is highlighted, with respect to the consistency of drug delivery.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Nasal Drug Delivery: Past, Present and Future Perspectives
Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation
Exploring the role of EI in partnerships for OINDP development
Publications, Pharmaceutical, Sustainability, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions
The Need to Scale Up Digital Health in the Post-Covid World
Webinars, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Innovation & Insights, Drug Delivery Innovations
Using Bioequivalence and Particle Size Distribution to Develop OINDPs
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions
